• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对C-C趋化因子受体CCR1制备特异性多克隆抗体,并测定CCR1在各类白细胞上的表达。

Preparation of specific polyclonal antibodies to a C-C chemokine receptor, CCR1, and determination of CCR1 expression on various types of leukocytes.

作者信息

Su S B, Mukaida N, Wang J, Nomura H, Matsushima K

机构信息

Department of Pharmacology, Cancer Research Institute, Kanazawa University, Japan.

出版信息

J Leukoc Biol. 1996 Nov;60(5):658-66. doi: 10.1002/jlb.60.5.658.

DOI:10.1002/jlb.60.5.658
PMID:8929558
Abstract

cDNA cloning has revealed the presence of at least three distinct human receptors for macrophage inflammatory protein-1alpha (MIP-1alpha) and RANTES: C-C chemokine receptor (CCR) 1, 4, and 5. To clarify the physiological role of CCR1, we prepared specific antibodies to CCR1 by immunizing rabbits with recombinant glutathione-S-transferase (GST) fused with its NH2-terminal portion. The resultant antibodies stained positively 293 cells transfected with CCR1 cDNA but neither parental cells nor cells transfected with CXCR1 [interleukin-8 (IL-8) receptor type A] cDNA, confirming its specificity. Immunofluorescence analysis revealed that peripheral blood lymphocytes and monocytes but not neutrophils express CCR1. Positive staining of transfectants, monocytes, and lymphocytes was inhibited by the GST protein fused with the NH2-terminal portion of CCR1, further indicating that this antibody recognized the NH2-terminal portion of CC CKR1. A majority of CD3+, CD4+, CD8+, or CD16+ peripheral blood lymphocytes but not CD19+ lymphocytes expressed CCR1. Among CD4+ peripheral blood lymphocytes, CD45RO+ cells expressed a larger number of CCR1 compared with CD45RO-. Moreover, CD34+ cells in human bone marrow as well as cord blood were uniformly stained with this antibody. Furthermore, the antibody inhibited calcium mobilization in CCR1 transfectants stimulated with human rMIP-1alpha, suggesting that its NH2-terminal portion is critically involved in ligand binding or signaling. Finally, the antibody partially inhibited monocyte chemotactic activities of human rMIP-1alpha, suggesting that CCR1 is a functional receptor for MIP-1alpha on human peripheral blood monocytes.

摘要

互补DNA(cDNA)克隆已揭示,巨噬细胞炎性蛋白-1α(MIP-1α)和调节激活正常T细胞表达和分泌因子(RANTES)至少存在三种不同的人类受体:C-C趋化因子受体(CCR)1、4和5。为阐明CCR1的生理作用,我们通过用与其氨基末端部分融合的重组谷胱甘肽-S-转移酶(GST)免疫兔子,制备了针对CCR1的特异性抗体。所得抗体对用CCR1 cDNA转染的293细胞呈阳性染色,但对亲本细胞或用CXCR1[白细胞介素-8(IL-8)A型受体]cDNA转染的细胞均无阳性染色,证实了其特异性。免疫荧光分析显示,外周血淋巴细胞和单核细胞而非中性粒细胞表达CCR1。转染细胞、单核细胞和淋巴细胞的阳性染色被与CCR1氨基末端部分融合的GST蛋白抑制,进一步表明该抗体识别CC CKR1的氨基末端部分。大多数外周血CD3⁺、CD4⁺、CD8⁺或CD16⁺淋巴细胞而非CD19⁺淋巴细胞表达CCR1。在CD4⁺外周血淋巴细胞中 Compared with CD45RO- cells, CD45RO+ cells expressed a larger number of CCR1.此外,人骨髓以及脐带血中的CD34⁺细胞均被该抗体均匀染色。此外,该抗体抑制了用人重组MIP-1α刺激的CCR1转染细胞中的钙动员,表明其氨基末端部分在配体结合或信号传导中起关键作用。最后,该抗体部分抑制了人重组MIP-1α的单核细胞趋化活性,表明CCR1是人类外周血单核细胞上MIP-1α的功能性受体。 (注:原文中“Among CD4+ peripheral blood lymphocytes, CD45RO+ cells expressed a larger number of CCR1 compared with CD45RO-.”翻译时语序调整了一下,使表达更通顺。)

相似文献

1
Preparation of specific polyclonal antibodies to a C-C chemokine receptor, CCR1, and determination of CCR1 expression on various types of leukocytes.针对C-C趋化因子受体CCR1制备特异性多克隆抗体,并测定CCR1在各类白细胞上的表达。
J Leukoc Biol. 1996 Nov;60(5):658-66. doi: 10.1002/jlb.60.5.658.
2
Inhibition of immature erythroid progenitor cell proliferation by macrophage inflammatory protein-1alpha by interacting mainly with a C-C chemokine receptor, CCR1.巨噬细胞炎性蛋白-1α主要通过与C-C趋化因子受体CCR1相互作用来抑制未成熟红细胞祖细胞的增殖。
Blood. 1997 Jul 15;90(2):605-11.
3
MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.作用于CCR1受体的MIP-1α[CCL3]通过依次释放肿瘤坏死因子-α(TNF-α)和白三烯B4(LTB4)介导免疫炎症中的中性粒细胞迁移。
J Leukoc Biol. 2005 Jul;78(1):167-77. doi: 10.1189/jlb.0404237. Epub 2005 Apr 14.
4
Differential response of CD34+ cells isolated from cord blood and bone marrow to MIP-1 alpha and the expression of MIP-1 alpha receptors on these immature cells.从脐带血和骨髓中分离出的CD34+细胞对MIP-1α的不同反应以及这些未成熟细胞上MIP-1α受体的表达。
Stem Cells. 1998;16(5):349-56. doi: 10.1002/stem.160349.
5
Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1.缺乏CC趋化因子受体1的小鼠的宿主防御、造血功能、肉芽肿性炎症及1型-2型细胞因子平衡受损。
J Exp Med. 1997 Jun 2;185(11):1959-68. doi: 10.1084/jem.185.11.1959.
6
Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors.单核细胞趋化蛋白-2(MCP-2)以CCR1和CCR2B作为其功能性受体。
J Biol Chem. 1997 May 2;272(18):11682-5. doi: 10.1074/jbc.272.18.11682.
7
CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.CCR1趋化因子促进破骨细胞的趋化募集、RANKL发育及运动,并由成骨细胞中的炎性细胞因子诱导产生。
J Bone Miner Res. 2004 Dec;19(12):2065-77. doi: 10.1359/JBMR.040910. Epub 2004 Sep 20.
8
Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils.巨噬细胞炎性蛋白-1α的天然LD78β亚型对CC趋化因子受体1、3和5的不同结合能力影响其抗HIV-1活性以及对嗜中性粒细胞和嗜酸性粒细胞的趋化能力。
Eur J Immunol. 2001 Jul;31(7):2170-8. doi: 10.1002/1521-4141(200107)31:7<2170::aid-immu2170>3.0.co;2-d.
9
Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages.在人单核细胞分化为巨噬细胞的过程中,CCR1和CCR5表达增加,且对MIP-1α的功能反应增强。
J Leukoc Biol. 2001 Feb;69(2):248-52.
10
Expression of macrophage inflammatory protein-1 receptors in human CD34(+) hematopoietic cells and their modulation by tumor necrosis factor-alpha and interferon-gamma.巨噬细胞炎性蛋白-1受体在人CD34(+)造血细胞中的表达及其受肿瘤坏死因子-α和干扰素-γ的调节
Blood. 1998 Nov 1;92(9):3073-81.

引用本文的文献

1
LukMF' targets neutrophils to promote skin and soft tissue infection.LukMF' 靶向中性粒细胞以促进皮肤和软组织感染。
Sci Adv. 2025 Jul 4;11(27):eadr5240. doi: 10.1126/sciadv.adr5240.
2
Inhibition of Japanese encephalitis virus proliferation by long non-coding RNA SUSAJ1 in PK-15 cells.长链非编码 RNA SUSAJ1 通过抑制 PK-15 细胞中的日本脑炎病毒增殖。
Virol J. 2021 Jan 28;18(1):29. doi: 10.1186/s12985-021-01492-5.
3
Cigarette smoke-induced lung inflammation in COPD mediated via CCR1/JAK/STAT /NF-κB pathway.香烟烟雾诱导 COPD 中的肺部炎症通过 CCR1/JAK/STAT/NF-κB 通路介导。
Aging (Albany NY). 2020 May 28;12(10):9125-9138. doi: 10.18632/aging.103180.
4
The role of CCR1 and therapeutic effects of anti-CCL3 antibody in herpes simplex virus-induced Behçet's disease mouse model.CCR1 在单纯疱疹病毒诱导的白塞病小鼠模型中的作用及抗 CCL3 抗体的治疗效果。
Immunology. 2019 Nov;158(3):206-218. doi: 10.1111/imm.13102. Epub 2019 Sep 8.
5
Heterogeneity of Bovine Peripheral Blood Monocytes.牛外周血单核细胞的异质性
Front Immunol. 2017 Dec 19;8:1875. doi: 10.3389/fimmu.2017.01875. eCollection 2017.
6
Annulus fibrosus cells express and utilize C-C chemokine receptor 5 (CCR5) for migration.纤维环细胞表达并利用C-C趋化因子受体5(CCR5)进行迁移。
Spine J. 2017 May;17(5):720-726. doi: 10.1016/j.spinee.2017.01.010. Epub 2017 Jan 17.
7
Induction of the MCP chemokine cluster cascade in the periphery by cancer cell-derived Ccl3.癌细胞衍生的Ccl3在外周诱导MCP趋化因子簇级联反应。
Cancer Lett. 2017 Mar 28;389:49-58. doi: 10.1016/j.canlet.2016.12.028. Epub 2016 Dec 29.
8
Cytokines and Chemokines in Mycobacterium tuberculosis Infection.结核分枝杆菌感染中的细胞因子和趋化因子。
Microbiol Spectr. 2016 Oct;4(5). doi: 10.1128/microbiolspec.TBTB2-0018-2016.
9
Differential Roles of Chemokines CCL2 and CCL7 in Monocytosis and Leukocyte Migration during West Nile Virus Infection.趋化因子CCL2和CCL7在西尼罗河病毒感染期间单核细胞增多和白细胞迁移中的不同作用
J Immunol. 2015 Nov 1;195(9):4306-18. doi: 10.4049/jimmunol.1500352. Epub 2015 Sep 23.
10
Beta-Chemokine CCL15 Affects the Adhesion and Migration of Hematopoietic Progenitor Cells.β-趋化因子CCL15影响造血祖细胞的黏附和迁移。
Transfus Med Hemother. 2015 Jan;42(1):29-37. doi: 10.1159/000370168. Epub 2014 Dec 19.